Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transplant Oncology”

4,367 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,367 results

Post-approval studies (Phase 4)Study completedNCT02866695
What this trial is testing

Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients

Who this might be right for
Actinic Keratosis
University of California, San Francisco 20
Testing effectiveness (Phase 2)UnknownNCT04507477
What this trial is testing

Ex-vivo Delivery of Rituximab to Prevent PTLD in EBV Mismatch Lung Transplant Recipients: A Pilot Trial

Who this might be right for
Epstein-Barr Virus InfectionsPost-transplant Lymphoproliferative Disorder
University Health Network, Toronto 10
Testing effectiveness (Phase 2)Study completedNCT01225419
What this trial is testing

Mobilization by Plerixafor of Haematopoietic Stem Cells in Children

Who this might be right for
Children Cancer, Solid Tumor
University Hospital, Clermont-Ferrand 5
Post-approval studies (Phase 4)UnknownNCT00838019
What this trial is testing

Intrabone Cord Blood Transplantation

Who this might be right for
Hematological Malignancies
Hospital Clinic of Barcelona 10
Testing effectiveness (Phase 2)Study completedNCT00002619
What this trial is testing

Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors

Who this might be right for
Brain and Central Nervous System Tumors
NYU Langone Health 60
Not applicableEnded earlyNCT05611307
What this trial is testing

Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors

Who this might be right for
Testicular CancerSurvivorshipASCVD+5 more
Indiana University 31
Not applicableLooking for participantsNCT06509945
What this trial is testing

Allo-PBSCT as the First-line Treatment for Patients With the High-risk PTCL

Who this might be right for
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50
Not applicableStudy completedNCT00521430
What this trial is testing

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Asan Medical Center 30
Testing effectiveness (Phase 2)UnknownNCT01423175
What this trial is testing

ClAraC or FLAMSA Followed by Stem Cell Transplantation to Treat High Risk AML or Advanced MDS

Who this might be right for
Acute Myeloid LeukemiaMDS
Hannover Medical School 60
Not applicableUnknownNCT00449319
What this trial is testing

AML Treatment in Untreated Adult Patients

Who this might be right for
Leukemia, Myelocytic, Acute
Gruppo Italiano Malattie EMatologiche dell'Adulto
Large-scale testing (Phase 3)Not Yet RecruitingNCT06724237
What this trial is testing

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeFollicular Helper T-Cell LymphomaFollicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type+1 more
Eastern Cooperative Oncology Group
Not applicableStudy completedNCT01904175
What this trial is testing

Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant

Who this might be right for
Hodgkin's DiseaseNon Hodgkin's LymphomaMyeloma+2 more
Duke University 48
Testing effectiveness (Phase 2)Ended earlyNCT01699581
What this trial is testing

Assessment of Impact Nutritional Program During Autologous Stem Cell Transplant

Who this might be right for
Hodgkin's LymphomaMultiple MyelomaNon-Hodgkin's Lymphoma
Greg Monohan 35
Early research (Phase 1)WithdrawnNCT00972101
What this trial is testing

Infusion of Expanded Cord Blood T Cells

Who this might be right for
Stem Cell TransplantationLeukemiaLymphoma+1 more
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00329030
What this trial is testing

Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)

Who this might be right for
Lymphoma, B-CellLymphoma, Large-Cell, ImmunoblasticLymphoma, Non-Hodgkin
National Heart, Lung, and Blood Institute (NHLBI) 224
Early research (Phase 1)Not Yet RecruitingNCT07254793
What this trial is testing

Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

Who this might be right for
Acute Lymphoid LeukemiaAcute Myeloid LeukemiaAcute Undifferentiated Leukemia (AUL)+3 more
University of Arizona 94
Testing effectiveness (Phase 2)Looking for participantsNCT07106736
What this trial is testing

MRD-Adaptive Guided Immunotherapy With CAR-T for Transplant-Ineligible Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma, Newly Diagnosed
Institute of Hematology & Blood Diseases Hospital, China 60
Testing effectiveness (Phase 2)Study completedNCT02405364
What this trial is testing

Front-line Therapy With Carfilzomib, Lenalidomide, and Dexamethasone Induction

Who this might be right for
Multiple Myeloma
University Hospital, Toulouse 46
Large-scale testing (Phase 3)UnknownNCT04000698
What this trial is testing

Personalized Targeted Preparative Regimen Before T-depleted Allogeneic HSCT in Children With Chemoresistent Acute Leukemias

Who this might be right for
Refractory Acute Myeloid LeukemiaRefractory Acute Lymphoblastic Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 25
Testing effectiveness (Phase 2)WithdrawnNCT01652014
What this trial is testing

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more
University of Medicine and Dentistry of New Jersey
Load More Results
294